Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2017, Article ID 5456219, 6 pages
https://doi.org/10.1155/2017/5456219
Research Article

Evaluating Adherence to Antiretroviral Therapy Using Pharmacy Refill Records in a Rural Treatment Site in South Africa

1HIV/AIDS & Global Health Research Programme, University of Venda, Thohoyandou, South Africa
2Department of Medical Laboratory Sciences, Kenyatta University, Nairobi, Kenya
3Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA
4Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA, USA
5HIV/AIDS Prevention Group Wellness and Health Clinic, Bela Bela, South Africa

Correspondence should be addressed to Pascal O. Bessong; az.ca.nevinu@gnosseb

Received 28 September 2016; Accepted 12 January 2017; Published 31 January 2017

Academic Editor: Robert R. Redfield

Copyright © 2017 George Gachara et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Hamers, K. C. E. Sigaloff, C. Kityo, P. Mugyenyi, and T. F. R. De Wit, “Emerging HIV-1 drug resistance after roll-out of antiretroviral therapy in sub-Saharan Africa,” Current Opinion in HIV and AIDS, vol. 8, no. 1, pp. 19–26, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. B. J. Turner, “Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients,” Journal of Infectious Diseases, vol. 185, no. 2, pp. S143–S151, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Z. Sangeda, F. Mosha, M. Prosperi et al., “Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings,” BMC Public Health, vol. 14, no. 1, article no. 1035, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. J. M. Nwobegahay, P. O. Bessong, T. M. Masebe, L. G. Mavhandu, B. C. Iweriebor, and G. Selabe, “Prevalence of antiretroviral drug resistance mutations and HIV-1 subtypes among newly-diagnosed drug-naïve persons visiting a voluntary testing and counselling centre in northeastern South Africa,” Journal of Health, Population and Nutrition, vol. 29, no. 4, pp. 303–309, 2011. View at Google Scholar · View at Scopus
  5. South Africa Department of Health, The South African Antiretrovial Treatment Guidelines 2013, 2013 http://www.kznhealth.gov.za/medicine/2013_art_guidelines.pdf.
  6. South Africa Department of Health, Operational plan for comprehensive HIV and AIDS care and treatment for South Africa, 2003, http://www.hsph.harvard.edu/population/aids/southafrica.aids.03.pdf.
  7. South Africa Department of Health, The South African antiretroviral treatment guidelines, 2010, http://apps.who.int/medicinedocs/documents/s19153en/s19153en.pdf.
  8. B. H. Chi, R. A. Cantrell, I. Zulu et al., “Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia,” International Journal of Epidemiology, vol. 38, no. 3, pp. 746–756, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. D. Lawn, L.-G. Bekker, and R. F. Miller, “Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals,” Lancet Infectious Diseases, vol. 5, no. 6, pp. 361–373, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. L. A. de Souza Neves, R. K. Reis, and E. Gir, “Compliance with the treatment by patients with the co-infection HIV/tuberculosis: integrative literature review,” Revista da Escola de Enfermagem, vol. 44, no. 4, pp. 1135–1141, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. B. Nachega, J.-J. Parienti, O. A. Uthman et al., “Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: a meta-analysis of randomized controlled trials,” Clinical Infectious Diseases, vol. 58, no. 9, pp. 1297–1307, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. A. B. Kobin and N. U. Sheth, “Levels of adherence required for virologic suppression among newer antiretroviral medications,” Annals of Pharmacotherapy, vol. 45, no. 3, pp. 372–379, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. D. L. Paterson, S. Swindells, J. Mohr et al., “Adherence to protease inhibitor therapy and outcomes in patients with HIV infection,” Annals of Internal Medicine, vol. 133, no. 1, pp. 21–30, 2000. View at Google Scholar · View at Scopus